Jean-Paul Clozel Net Worth

Jean-Paul Clozel, a cardiologist born in Basel, Switzerland, cofounded the Swiss pharmaceutical firm Actelion in 1997 with his wife, Martine, and three other colleagues. Actelion specializes in drugs for orphan diseases, which affect fewer than 200,000 people and typically receive little research funding. In January 2017, Johnson & Johnson announced a $30 billion takeover bid for Actelion, causing the company's shares to surge.
Jean-Paul Clozel is a member of Healthcare

Age, Biography and Wiki

Birth Day January 29, 1947
Birth Place Basel, Switzerland, Switzerland
Age 77 YEARS OLD
Birth Sign Aquarius
Education Sciences Po, ÉNA, University of Chicago,
Occupation Civil servant
Spouse(s) Nicolas Droin (m. 2013)

💰 Net worth: $1.2 Billion (2024)

Jean-Paul Clozel, a prominent figure in the healthcare sector in Switzerland, is estimated to have a net worth of $1.2 billion in 2024. As a renowned pharmaceutical entrepreneur, Clozel has made invaluable contributions to the field of healthcare through his leadership roles. He co-founded the biopharmaceutical company Actelion Pharmaceuticals Ltd., which has achieved remarkable success. With his vast knowledge and expertise, Clozel has not only revolutionized the medical industry but has also been instrumental in advancing medical treatments and enhancing patient care. His immense wealth reflects his outstanding achievements and enduring impact in the healthcare landscape.

Biography/Timeline

1947

Cluzel was born on January 29, 1947 and lived in Le Kremlin-Bicêtre, a suburb of Paris, France, until he was 14. His parents worked in a hardware store. He studied in the École nationale d'administration from 1970 until 1972, the Institut d'Études Politiques de Paris, Panthéon-Assas University, and the University of Chicago, where he received a Master of Arts.